PRIMECAP Management's position in Biomarin Pharmaceutical - Registered Shares is currently worth $1.51 Billion. That's 1.12% of their equity portfolio (24th largest holding). The investor owns 9.47% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2013. Since then PRIMECAP Management bought shares 22 more times and sold shares on 21 occasions. The stake costed the investor $1.38 Billion, netting the investor a gain of 9.5% so far.
PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc
GuruFocus, 3 months ago… by institutional investors. BioMarin Pharmaceutical Price Performance BMRN opened at … Sanford C. Bernstein upgraded BioMarin Pharmaceutical from an “under...
EIN News Pharmaceuticals, 4 months agoBiomarin (BMRN) stock rose after activist Elliott Management enteraed a cooepratoon pact and a strategic review committee was established
Seeking Alpha, 5 months agoBioMarin (BMRN) said it has established a strategic review committee, temporarily expanded its board and entered into a cooperation agreement with Elliott In...
Seeking Alpha, 5 months ago